Marriott Forecast, price target & analysts
Marriott Target price 2026 - Analyst rating & recommendation
Marriott Classifications & Recommendation
Marriott Price Target
| Target Price | $400.86 |
| Price | $351.66 |
| Potential | 13.99% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Marriott 2027 . The average Marriott target price is $400.86. This is 13.99% higher than the current stock price. The highest price target is $446.25 26.90% , the lowest is $282.80 19.58% . | |
| A rating was issued by 32 analysts: 16 Analysts recommend Marriott to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2027 of 13.99% . Most analysts recommend the Marriott stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
29 Analysts have issued a sales forecast Marriott 2026 . The average Marriott sales estimate is
This results in the following potential growth metrics:
28 Analysts have issued an Marriott EBITDA forecast 2026. The average Marriott EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Marriott Analysts have issued a net profit forecast 2026. The average Marriott net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
30 Analysts have issued a Marriott forecast for earnings per share. The average Marriott EPS is
This results in the following potential growth metrics and future valuations:
Current Marriott Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Sep 10 2026 |
| Wolfe Research |
➜
Peer Perform
|
Initiated | Sep 02 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Aug 20 2026 |
| CICC |
➜
Outperform
|
Initiated | Aug 12 2026 |
| Macquarie |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2026 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Aug 04 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 04 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Sep 10 2026 |
|
Initiated
Wolfe Research:
➜
Peer Perform
|
Sep 02 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Aug 20 2026 |
|
Initiated
CICC:
➜
Outperform
|
Aug 12 2026 |
|
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Aug 05 2026 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Aug 04 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Aug 04 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
